التفاصيل البيبلوغرافية
| العنوان: |
A novel Gd3+ DTPA-bisamide complex with high relaxivity as an MRI contrast agent. |
| المؤلفون: |
Ru, Jiaxi, Xu, Weiyuan, Kou, Manchang, Dong, Hu, Tang, Xiaoliang, Chen, Yu, Kang, Lingling, Dai, Lixiong, Liang, Chao |
| المصدر: |
Journal of Materials Chemistry B; 8/14/2023, Vol. 11 Issue 30, p7182-7189, 8p |
| مستخلص: |
A novel Gd(III) complex-based magnetic resonance imaging (MRI) contrast agent GdL has been designed and synthesized, which exhibited a much higher relaxivity (7.8 mM−1 s−1) than the commercially used Magnevist® (3.5 mM−1 s−1), good water solubility (>100 mg mL−1), excellent thermodynamic stability (log KGdL = 17.21 ± 0.27), high biosafety and biocompatibility. In particular, the relaxivity of GdL increased to 26.7 mM−1 s−1 in a 4.5% bovine serum albumin (BSA) solution at 1.5 T, which was not significant in other commercial MRI contrast agents. The interaction sites and interaction types of GdL and BSA were further demonstrated by molecular docking simulations. Furthermore, the in vivo MRI behaviour was evaluated by using a 4T1 tumour-bearing mouse model. These results suggested that GdL is an excellent T1-weighted MRI contrast agent and has the potential to be applied in clinical diagnosis. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Materials Chemistry B is the property of Royal Society of Chemistry and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |